Confronting organized complexity by Godovac-Zimmermann, J
THE CONCEPTS OF biology at the cellular, 
organismal, ecological and evolutionary levels 
continue to develop rapidly. Increasingly, 
biologists need to confront organised 
complexity, of which living systems are the 
paramount example. Both spontaneous 
emergence of order and the maintenance of 
stability in complex systems in the face of highly 
variable environments need to be researched 
further.  Complex structures are generated and 
maintained through energy ﬂ ux, placing energy 
ﬂ ow as one of the most important components 
of biological systems. In addition, diversity, 
whether of molecular form at the cellular level 
or organismal variation at the ecological level, 
is another crucial characteristic of biological 
systems.
Exploitation of the human genome in systems 
biology has tended to concentrate on the 
amounts of gene expression, although it is well-
known that over 50 per cent of eukaryotic genes 
generate multiple transcriptional variants and a 
majority of proteins are subject to various kinds 
of functionally important post-translational 
modiﬁ cations. It is also known that cells invest 
more energy in establishing and maintaining 
subcellular distributions and ﬂ uxes of various 
molecules, including proteins, than they invest 
in protein synthesis, but knowledge of the 
spatio-temporal ﬂ uxes of proteins at subcellular 
levels remains rudimentary. 
INVESTIGATING COMPLEXITIES
Professor Jasminka Godovac-Zimmermann 
is leading a team of researchers at University 
College London which has recently established 
high-throughput proteomics methods that 
can address some of these complexities. 
The group aims to address the inﬂ uence of 
diversity of molecular form and/or function, 
quantity (abundance), space (subcellular spatial 
distribution) and time (dynamic responses) at 
the cellular level. 
Protein diverse functions and locations
Researchers at University College London are using high-throughput proteomics methods to research the spatio-
temporal ﬂ uxes of proteins at subcellular levels, which has implications for the understanding of cellular function
Working within the area of proteomics, with a particular focus on cancer, mitochondria and 
subcellular location, Professor Jasminka Godovac-Zimmermann discusses her far-reaching research 
investigating the dynamics of cellular function through a systems biology approach
To begin, could you explain why biologists 
need to confront organised complexity?
At the cell biology level, it is increasingly 
clear that the basic functional units are 
complex networks of interacting proteins 
and other molecular types, including ions, 
small molecules and RNA. These networks 
are dynamic, of non-homogeneous spatial 
distribution and variable composition, and 
have functional output that depends on 
dynamic inclusion/exclusion/exchange/
modiﬁ cation of proteins and other molecules. 
At the single protein level, this is increasingly 
shown by proteins that are involved in 
different functions, at different subcellular 
locations, and at different temporal stages 
of cellular state. At the level of single cell 
organisms, very basic functions can be 
spatially organised very differently. How these 
variable functional networks are established, 
maintained, exploited and evolve represents a 
higher level interpretation of the living state. 
Understanding the dynamic, organisational 
principles of such networks offers new 
prospects for applications in many ﬁ elds. 
Could you elaborate on how you came 
to study the complex organisation of 
subcellular biology in relationship to 
the energetic/integrative functions of 
mitochondria?
It has long been clear that the energetic 
properties of mitochondria are intimately 
connected to many facets of cellular function 
and a variety of diseases, even to the point 
where some scientists have championed 
the idea that cancer is primarily a metabolic 
disease involving energetic functions of 
mitochondria. We know that mitochondria 
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are also involved in such diverse functions 
as programmed cell death or viral immune 
response. Furthermore, we know that 
elaborate systems exist to import proteins 
into mitochondria, and recently, systems 
that export proteins from mitochondria 
have also been identiﬁ ed. Finally, we know 
that mitochondria are highly dynamic 
organelles that change their morphology 
and their interactions with other subcellular 
organelles. Given all these punctual indications, 
we decided it was time to systematically 
investigate the dynamic characteristics of 
the mitochondrial proteome and how this is 
related to cellular function and disease.
What might account for the inertia in 
challenging the one gene-one protein 
dogma?
It is already largely accepted that the one 
gene gives one protein dogma is inadequate. 
However, because many of our common 
experimental tools do not deal adequately 
with multiple protein transcriptional/post-
transcriptional isoforms or with dynamic 
redistribution of subcellular location, there 
remains the inertia that many experimental 
strategies essentially ignore these crucial 
features of cells and look instead for function 
at the location. Unconsciously we are still using 
the corollary to the dogma that one protein 
gives one location gives one function. We need 
instead to ask how some single gene products 
may be involved in coordinated, spatially 
distributed, dynamic responses of cells to 
changes in their state and environment. For this 
we need to update our experimental methods.
You propose that altered nucleo-
cytoplasmic shuttling may play a key role in 
the regulation of cell cycle arrest and in the 
coordination of related functions across a 
diversity of subcellular locations. How close 
are you to proving this hypothesis and what 
is its implication?
We have recently found that the distribution 
of numerous proteins between the nucleus 
and the rest of the cell is changed by cell 
cycle arrest. We have also shown that the 
abundance of key proteins involved in 
nucleo-cytoplasmic shuttling is changed 
by cell cycle arrest. The most tantalising 
observation is that numerous proteins with 
known functions elsewhere in the cell, such 
as mitochondria or lysosomes, are present 
in the nucleus and their abundance there is 
changed by cell cycle arrest. Some of these 
proteins have previously been observed in the 
nucleus by others, but their function there is 
often completely unknown. 
We are now developing high-throughput 
methods designed to give indications of the 
nature of the function for proteins in the 
‘wrong’ location compared to their presently 
known functions. Although we are currently 
concentrating on nuclear translocation, we 
expect that dynamic spatial translocations 
throughout the cell are an essential feature of 
cellular function.
What are the potential ramifi cations of 
proteomics in other fi elds such as physics, 
economics and sociology?
The living, complex systems that we try to 
study with proteomics have implications 
in many other ﬁ elds. The nature of self-
organisation and maintenance of stability in 
complex systems is incompletely understood, 
but has obvious ramiﬁ cations for social 
organisation and in areas such as markets and 
economics. The technology for perturbing 
complex cellular systems and studying 
dynamic response provides us with controlled 
examples of complex systems so we can model 
their behaviour.
The investigation has involved work which 
suggests that multiple locations of proteins, 
with the possibility of participation in different 
functions at different locations, is a crucial, 
generalised characteristic of cells. This poses the 
question of whether the purpose and function 
of subcellular organelles is really understood: 
could they simply be a transient agglomeration 
of cellular components where certain events or 
tasks take place and where proteins come and 
go, as overall cellular metabolism dictates the 
need for different levels of specialised functions? 
The researchers have adopted proteomics 
methods to show that at least 50 per cent of 
proteins detected in MCF7 breast cancer cells 
show multiple locations involving signiﬁ cant 
proportions of each protein, and that large 
numbers of the same proteins are present in 
multiple subcellular organelles such as nuclei 
and mitochondria. “Our observations are a 
key contradiction to the ‘one protein gives one 
subcellular location gives one function’ dogma, 
as we found that many proteins have multiple 
locations and might have different functions 
in different locations,” Godovac-Zimmermann 
enthuses. “This suggests that transcription of 
DNA may be a warehouse phenomenon – as 
cells respond to altered environment, they 
undergo dynamic, coordinated reorganisation 
of functional networks that result in ordering 
and delivering of new cellular components 
from the warehouse”. Spatial distribution 
and translocation of key proteins increasingly 
seems to be an essential component of cellular 
response and subsequent transcriptional 
changes.
CDC7 INHIBITORS
The cell cycle is a crucial nexus in cellular 
activities; changes of events in the cell cycle may 
be a cause of cancer. Godovac-Zimmermann’s 
group with GH Williams and K Stoeber have 
elucidated the proteomics and the functional 
architecture of a novel origin activation 
checkpoint in the G1 phase of the mitotic cell 
cycle, which can be triggered by loss of DNA 
replication initiation factors such as the Cdc7 
kinase. Insufﬁ cient levels of Cdc7 produce cell 
cycle arrest in normal cells, whereas cancer cells 
appear to lack this checkpoint response, leading 
to cell death. The differential response between 
normal and tumour cells at this checkpoint has 
led to widespread interest in the development 
of pharmacological Cdc7 inhibitors as novel 
anti-cancer agents.
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FIGURE 1. INVESTIGATING ORGANISED
 COMPLEXITY IN HUMAN FIBROBLASTS
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proteins, especially more complete MS-based 
characterisation of transcriptional form and 
modiﬁ cations.
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The experiments combine three technologies. 
RNAi suppression is used to introduce a 
controlled, deﬁ ned perturbation that reduces the 
cellular abundance of Cdc7, and stable isotope 
labelling of amino acids in cell culture (SILAC) 
is used to produce two types of cell populations 
both with, and without RNAi suppression and 
isotope labelling. After mixing the two types, high 
resolution MS proteomics is used to monitor the 
changes in abundance of thousands of proteins in 
response to Cdc7 suppression. 
Bioinformatics analysis was able to identify clear 
changes in wide-ranging biological processes 
including altered cellular energetic ﬂ ux and 
a spatially-distributed response across the 
mitochondria, lysosomes and the cell surface. 
These results provide a quantitative overview 
of the processes involved in maintenance of the 
arrested state and show that this phenotype 
involves active rather than passive cellular 
adaptation. They also highlight a diverse set 
of proteins responsible for cell cycle arrest and 
ultimately for promotion of cellular survival.
DATABASE LIMITATIONS
Screens of protein abundance by high-
throughput proteomics continue to advance 
rapidly; they are now delivering unparalleled 
information regarding protein changes 
associated with speciﬁ c cellular responses. 
However, there is an urgent need for better 
incorporation of experimental information into 
databases. A full description of a protein and its 
functions would consist of at least a ﬁ ve-tuplet 
of information: exact transcriptional form; post-
translational modiﬁ cations; subcellular location; 
function and interaction partners. There are now 
many cases known in which the same protein, 
or variants from the same gene, are known to 
constitute several independent ﬁ ve-tuplets.
Current databases usually consist of 
independent listings of each type of information 
without the integrated information of a 
coordinated ﬁ ve-tuplet. This may devalue the 
database for systems biology searches for 
functional networks or lead to uncertainty: “It 
is confusing when only part of the information 
available in the experimental literature has been 
incorporated into the databases,” Godovac-
Zimmermann reﬂ ects. “The spatial locations, 
interaction partners and exact transcriptional 
and post-translational isoforms are not 
measured or are not recorded.” Databases 
need to be able to record coordinated tuplets 
and to deal with partial information depending 
on which elements of a complete tuplet are 
established for any particular experimental 
strategy. It is highly desirable therefore that 
many conventional biological experiments are 
coupled with MS-based proteomics methods 
that validate protein form and modiﬁ cations for 
crucial proteins.
FUTURE GOALS
The team’s next goal is to develop tools that 
can rapidly and completely validate tuplets 
for moderate numbers of candidate proteins 
identiﬁ ed by systems-wide screens. There are 
two important immediate tasks: validation 
of subcellular location and establishment of 
possible functional participations by capture and 
characterisation of protein complexes from speciﬁ c 
subcellular locations; and exact characterisation 
of tuplets, especially more complete MS-based 
characterisation of form and modiﬁ cations. 
For example, it is increasingly recognised that 
‘cytosolic’ glycolytic enzymes are also present 
in the nucleus. Nuclear form, modiﬁ cation 
and function have been partially characterised 
for a few of them (but not recorded as 
coordinated tuplets in databases), which turn 
out to be critically involved in energetic changes 
connected with proliferating cells and various 
kinds of cancers, as well as with the cell cycle.
Godovac-Zimmermann and her collaborators 
have now identiﬁ ed a substantial number 
of proteins that participate in speciﬁ c, well-
characterised mitochondrial functions, but are 
also present in the nucleus. In some cases their 
presence has also been noted by others, but 
their nuclear functions are often completely 
unknown. The next question to tackle is what 
they are doing there, and whether these proteins 
have been to, and returned from, mitochondria. 
In this case, their forms and processing may 
show characteristics of their functional history. 
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FIGURE 2. OXIDATIVE PHOSPHORYLATION PROTEINS 
OF THE MITOCHONDRIAL MATRIX/INNER MEMBRANE 
ALSO PRESENT IN THE NUCLEUS (RED/GREEN)
